Skip to main content

ADVERTISEMENT

immune-oncology

Department
09/30/2016
JCP Editors
Researchers at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, have identified a potential biomarker in patients with stage IV melanoma being treated with the immunotherapy...
Researchers at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, have identified a potential biomarker in patients with stage IV melanoma being treated with the immunotherapy...
...
09/30/2016
Journal of Clinical Pathways